We present 2 cases of intracranial myxoid mesenchymal tumor with EWSR1-CREB gene fusion who have long-term follow-up currently demonstrating an absence of progression in both, one of which in response to targeted crizotinib monotherapy. Here, EWSR1 is linked to mesenchymal cell neoplasm.